Market Overview:
The global inkjet-based 3D bioprinting market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for 3D printing technology in medical and scientific research applications. In addition, the growing awareness about the benefits of 3D printing technology is also contributing to the growth of this market. The global inkjet-based 3D bioprinting market can be segmented on the basis of type, application, and region. On the basis of type, this market can be segmented into printing equipment and printing material. Printing equipment includes printers, scanners, software etc., while printing material includes bioinks and biomaterials etc. On the basis of application, this market can be divided into medical applications such as tissue engineering & regenerative medicine (TERM), drug discovery & development (DD&D), implantable devices etc., scientific research applications such as cell biology & tissue culture studies; organoids; stem cells; CRISPR/Cas9 knockouts etc., and other applications including food science & nutrition; cosmetics & personal care products; aerospace engineering etc.
Product Definition:
Inkjet-based 3D bioprinting is the process of printing cells and other biological materials in three dimensions. This technology has many potential applications, including tissue engineering, drug testing, and regenerative medicine. Inkjet-based 3D bioprinting is important because it allows scientists to create three-dimensional structures out of living cells. This technology can be used to create tissues and organs for transplantation or to test new drugs or treatments.
Printing Equipment:
3D bioprinting is a technique that involves the use of inkjet technology to create living tissue. The process allows for rapid prototyping and offers high accuracy, which in turn is expected to drive the market growth over the forecast period.
Inkjet printing has gained popularity as it enables 3D bioprinting with minimum wastage of biological material and time taken for development & testing can be reduced drastically.
Printing Material:
3D bioprinting is a process of creating living tissue using inkjet technology. The process involves the use of bio-ink which is made up of living cells and a 3D printer to build the structure. It’s major advantage over other bioprinters is that it can create complex organs with multiple layers, in addition, it also allows for easy customization according to requirements.
Application Insights:
The other application segment held the largest share of over 50.0% in 2017 and is expected to witness significant growth during the forecast period owing to its wide applications, such as aerospace & defense. The medical application segment is also expected to witness considerable growth during the forecast period owing to its growing adoption for tissue engineering and bio-printing purposes.
Inkjet 3D bioprinting has numerous advantages as it can create complex tissues with a high degree of accuracy, specificity, and complexity at low cost compared with other fabrication methods such as stereolithography or laser sintering which are used for creating solid freeform parts. Furthermore, due to its ability to produce multiple identical copies, this technology is widely adopted in various research areas including stem cell therapy development and tissue engineering applications across several verticals (academic institutions/research centers).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of research organizations and universities that are actively involved in R&D activities for 3D bioprinting. The region is expected to maintain its dominance over the forecast period due to increasing government funding for biomedical engineering, technological advancements, and growing demand from clinical applications.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising healthcare expenditure by governments as well as private sectors in order to improve public health systems. In addition, favorable regulatory policies framed by governments across various countries are also expected favorably impact regional growth during the same period. ‰â€˜”‘”‘°' ♬' ♬' ♬'"'-.-.-.-.-.--.-'""""".''"""-._.
Growth Factors:
- Increasing demand for organ transplants due to rising incidence of organ failures and diseases
- Growing number of research institutes and funding for 3D bioprinting research
- Rising popularity of 3D printing technology across different industries
- Technological advancements in inkjet-based 3D bioprinting technology
- Increasing application areas of 3D bioprinted tissues and organs
Scope Of The Report
Report Attributes
Report Details
Report Title
Inkjet-based 3D Bioprinting Market Research Report
By Type
Printing Equipment, Printing Material
By Application
Medical, Scientific Research, Other
By Companies
3D Systems, Organovo, CELLINK, Envision TEC, Materialise NV, Bio3D Technologies, Oceanz 3D printing, Solidscape, Stratasys, Voxeljet
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Inkjet-based 3D Bioprinting Market Report Segments:
The global Inkjet-based 3D Bioprinting market is segmented on the basis of:
Types
Printing Equipment, Printing Material
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical, Scientific Research, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3D Systems
- Organovo
- CELLINK
- Envision TEC
- Materialise NV
- Bio3D Technologies
- Oceanz 3D printing
- Solidscape
- Stratasys
- Voxeljet
Highlights of The Inkjet-based 3D Bioprinting Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Printing Equipment
- Printing Material
- By Application:
- Medical
- Scientific Research
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Inkjet-based 3D Bioprinting Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Inkjet-based 3D Bioprinting is a process that uses inkjet printers to create three-dimensional objects from biological materials. The technology can be used to create customized medical implants, tissue replacements, and other medical devices.
Some of the key players operating in the inkjet-based 3d bioprinting market are 3D Systems, Organovo, CELLINK, Envision TEC, Materialise NV, Bio3D Technologies, Oceanz 3D printing, Solidscape, Stratasys, Voxeljet.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Inkjet-based 3D Bioprinting Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Inkjet-based 3D Bioprinting Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Inkjet-based 3D Bioprinting Market - Supply Chain
4.5. Global Inkjet-based 3D Bioprinting Market Forecast
4.5.1. Inkjet-based 3D Bioprinting Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Inkjet-based 3D Bioprinting Market Size (000 Units) and Y-o-Y Growth
4.5.3. Inkjet-based 3D Bioprinting Market Absolute $ Opportunity
5. Global Inkjet-based 3D Bioprinting Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Inkjet-based 3D Bioprinting Market Size and Volume Forecast by Type
5.3.1. Printing Equipment
5.3.2. Printing Material
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Inkjet-based 3D Bioprinting Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Inkjet-based 3D Bioprinting Market Size and Volume Forecast by Application
6.3.1. Medical
6.3.2. Scientific Research
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Inkjet-based 3D Bioprinting Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Inkjet-based 3D Bioprinting Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Inkjet-based 3D Bioprinting Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Inkjet-based 3D Bioprinting Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Inkjet-based 3D Bioprinting Demand Share Forecast, 2019-2026
9. North America Inkjet-based 3D Bioprinting Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Inkjet-based 3D Bioprinting Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Inkjet-based 3D Bioprinting Market Size and Volume Forecast by Application
9.4.1. Medical
9.4.2. Scientific Research
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Inkjet-based 3D Bioprinting Market Size and Volume Forecast by Type
9.7.1. Printing Equipment
9.7.2. Printing Material
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Inkjet-based 3D Bioprinting Demand Share Forecast, 2019-2026
10. Latin America Inkjet-based 3D Bioprinting Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Inkjet-based 3D Bioprinting Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Inkjet-based 3D Bioprinting Market Size and Volume Forecast by Application
10.4.1. Medical
10.4.2. Scientific Research
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Inkjet-based 3D Bioprinting Market Size and Volume Forecast by Type
10.7.1. Printing Equipment
10.7.2. Printing Material
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Inkjet-based 3D Bioprinting Demand Share Forecast, 2019-2026
11. Europe Inkjet-based 3D Bioprinting Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Inkjet-based 3D Bioprinting Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Inkjet-based 3D Bioprinting Market Size and Volume Forecast by Application
11.4.1. Medical
11.4.2. Scientific Research
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Inkjet-based 3D Bioprinting Market Size and Volume Forecast by Type
11.7.1. Printing Equipment
11.7.2. Printing Material
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Inkjet-based 3D Bioprinting Demand Share, 2019-2026
12. Asia Pacific Inkjet-based 3D Bioprinting Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Inkjet-based 3D Bioprinting Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Inkjet-based 3D Bioprinting Market Size and Volume Forecast by Application
12.4.1. Medical
12.4.2. Scientific Research
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Inkjet-based 3D Bioprinting Market Size and Volume Forecast by Type
12.7.1. Printing Equipment
12.7.2. Printing Material
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Inkjet-based 3D Bioprinting Demand Share, 2019-2026
13. Middle East & Africa Inkjet-based 3D Bioprinting Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Inkjet-based 3D Bioprinting Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Inkjet-based 3D Bioprinting Market Size and Volume Forecast by Application
13.4.1. Medical
13.4.2. Scientific Research
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Inkjet-based 3D Bioprinting Market Size and Volume Forecast by Type
13.7.1. Printing Equipment
13.7.2. Printing Material
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Inkjet-based 3D Bioprinting Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Inkjet-based 3D Bioprinting Market: Market Share Analysis
14.2. Inkjet-based 3D Bioprinting Distributors and Customers
14.3. Inkjet-based 3D Bioprinting Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. 3D Systems
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Organovo
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. CELLINK
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Envision TEC
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Materialise NV
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bio3D Technologies
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Oceanz 3D printing
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Solidscape
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Stratasys
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Voxeljet
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook